Kevin R. Bolen

Partner

Since joining Innosight in 2007, Kevin has supported a number of leaders and their teams as they seek to align their innovation portfolios, develop new growth opportunities, and transform or diversify their business model. Adopting a collaborative style, Kevin and the Innosight teams address not only the stated need but simultaneously establish deep innovation capabilities and a general culture of innovation within the client organization.

Kevin has balanced his career among management consulting, strategic planning, and marketing leadership roles in a variety of high growth environments. He has worked for and consulted with Fortune 500, mid-sized, and start-up enterprises in a variety of sectors including technology, healthcare, apparel/retail, financial services, and industrial/distribution.

Prior to joining Innosight in 2007, Kevin served as the Chief Marketing Officer of Lionbridge (NASDAQ: LIOX), a $450M global technology services company where he led a series of new market initiatives including launching the industry’s first SaaS-based collaboration environment and community-based sourcing model. During his six year tenure overseeing marketing and sales, the firm and its predecessor (Bowne Global Solutions) grew from $90M to $450M through organic expansion and strategic acquisitions.

Before Lionbridge, Kevin was engaged in creating product development and go-to-market strategies for several venture-backed software firms. Kevin began his career with IBM Global Services spending six years in a variety of strategic planning, marketing and consulting roles. His commentary and/or by-lined articles have appeared in: BusinessWeek, Forbes, Harvard Business Online, TIME, Pharmaceutical Executive and a host of IT trade publications. He is a regular speaker at corporate and trade events.

Kevin holds an MBA in Marketing and Management from the Stern School of Business at New York University and a BBA Summa Cum Laude in International Business from the Lubin School of Business at Pace University.

Publication Highlights

“Spearheading Innovation,” Forbes, December 16, 2010.

“Swallowing the Innovator’s RX,” PharmExec, July 2009.